NS-11021 is a novel, potent and selective activator of large-conductance Ca2+-activated potassium channels (BKCa, KCa1.1).

SB-705498 (SB705498; SB 705498) is an orally bioavailable and competitive antagonist of the capsaicin-mediated activation of TRPV1 (transient receptor potential vanilloid 1) receptors with important biological activity.

NS-1619 is a selective activator of the large conductance Ca2+-activated K+-channel (BKCa, KCa1.1).

Glyburide (formerly HB419; HB420; Glibenclamide; Micronase; Diabeta; Maninil; Micronase; Neogluconin) is a selective blocker of vascular ATP-sensitive K+ channels (KATP) that has been approved as an antidiabetic sulfonylurea drug used for the treatment of type 2 diabetes.

AUT1 is a Kv3 potassium channel modulator which increases whole currents mediated by human Kv3.1b and Kv3.2a channels, with a concomitant leftward shift in the voltage-dependence of activation, while having a less potent effect on hKv3.3 currents.

Minoxidil (U-10858; Loniten; Rogaine) is an antihypertensive agent and vasodilator that has also found usefulness in treatment of hair loss and alopecia areata when applied topically.

Dofetilide (formerly UK-68789; UK68789; Dofetilidum; Tikosyn) is a potent and selective potassium channel (hERG) blocker approved for use as a Class III antiarrhythmic drug.

Naminidil (BMS 234303-01) is a novel and potent cyanoguanidine KATP opener (ATP-Sensitive Potassium Channel Vasodilator).

Sematilide (formerly known as CK-1752) is a novel class III antiarrhythmic agent.

JNJ303 is a potent and specific inhibitor of heteromeric Kv7.1/KCNE1 channel complexes in a concentration- and time-dependent manner.